Doxazosin
1.
What is DOZOX and what is it used for
DOZOX belongs to a group of medicines called alpha-blockers. These medicines relax the blood vessels, which lowers blood pressure and makes it easier for the heart to pump blood around the body.
DOZOX is also an alpha-adrenergic blocking agent that acts on the prostate and bladder neck muscles. It helps to improve urine flow and reduces the symptoms of benign prostatic hyperplasia (enlargement of the prostate gland).
DOZOX is used to treat:
Before taking DOZOX, tell your doctor or pharmacist if:
Taking DOZOX during cataract surgery
If you are undergoing cataract surgery, tell your doctor about your current or past use of DOZOX. DOZOX may cause complications during surgery, which your doctor can manage if they are prepared.
DOZOX should not be used in children and adolescents under 18 years of age, as the safety and efficacy of doxazosin in this age group have not been established.
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including those obtained without a prescription, as they may interact with DOZOX:
The blood pressure-lowering effect of doxazosin may be reduced by:
Doxazosin may reduce the effect of dopamine, ephedrine, epinephrine, metaraminol, methoxamine, and phenylephrine on blood pressure and blood vessels. As there are no data on interactions with drugs that affect liver metabolism (such as cimetidine), caution should be exercised when administering these drugs with doxazosin.
In vitro studies have shown that doxazosin does not affect the binding of digoxin, warfarin, phenytoin, or indomethacin to plasma proteins.
In clinical studies, no interactions have been observed between doxazosin and thiazide diuretics, furosemide, beta-blockers, NSAIDs, antibiotics, oral hypoglycemic agents (used in diabetes), uricosuric agents, or anticoagulants.
Doxazosin may increase plasma renin activity and urinary vanillylmandelic acid excretion. This should be taken into account when interpreting laboratory results.
Doxazosin enhances the blood pressure-lowering effect of other alpha-blockers and other antihypertensive agents.
Clinical studies have shown that doxazosin has a beneficial effect on lipids, significantly reducing total triglycerides, total cholesterol, and LDL fraction in plasma. Treatment with doxazosin has a beneficial effect on hypertension and lipid levels, resulting in a reduced risk of coronary artery disease.
Some patients taking alpha-blockers for hypertension or enlarged prostate gland may experience dizziness or a feeling of emptiness in the head, which can be caused by low blood pressure. Some patients may experience these symptoms when taking erectile dysfunction medications with alpha-blockers. To minimize the likelihood of these symptoms, the patient should take their usual daily dose of alpha-blocker before taking an erectile dysfunction medication.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
The use of doxazosin has not been studied in pregnant women.
Breast-feeding
Doxazosin passes into human milk in small amounts. Breast-feeding women should not take this medicine unless their doctor decides it is necessary.
Due to individual reactions to doxazosin, the ability to perform tasks that require attention, such as driving vehicles or operating machinery, may be impaired, especially at the start of treatment, after a dose increase, or when switching to another medicine or consuming alcohol.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
The initial dose is 1 mg once daily. Depending on the response, your doctor may increase the dose to 2 mg of doxazosin once daily after 1 to 2 weeks. This dose is also maintained for 1 to 2 weeks. If necessary, the dose may be further increased to 4 mg or 8 mg once daily until the desired blood pressure reduction is achieved.
The maximum recommended daily dose is 16 mg.
To start treatment, the following dosing schedule is recommended:
day 1-8:
morning
1 mg doxazosin
day 9-14, morning
2 mg doxazosin
Then, the dose can be increased to the effective maintenance dose.
The initial dose is 1 mg once daily. If necessary, after 1 to 2 weeks, your doctor may increase the dose to 2 mg of doxazosin once daily. If after 1 to 2 weeks, a satisfactory effect has not been achieved, the dose may be increased to 4 mg once daily.
In some cases, the dose may be increased to a maximum of 8 mg once daily.
To start treatment, the following dosing schedule is recommended:
day 1-8:
1 mg doxazosin once daily
day 9-14, 2 mg doxazosin once daily
Then, the dose can be individually increased to the effective maintenance dose.
When using DOZOX, 4 mg, tablets, it is not possible to achieve a dose of 1 mg doxazosin. Therefore, if a dose of 1 mg is required, another medicine with the appropriate dose of doxazosin should be used.
No dose adjustment is necessary in patients with renal impairment. However, the dose of the medicine should be as low as possible, and any dose increase should be done under close medical supervision.
Caution should be exercised. There is no clinical experience with the use of this medicine in patients with severe liver dysfunction.
No dose adjustment is necessary in elderly patients. However, the dose of the medicine should be as low as possible, and any dose increase should be done under close medical supervision.
The safety and efficacy of doxazosin in children have not been established.
If you take more than the prescribed dose, you may experience hypotension. If you have taken more than the prescribed dose, contact your doctor immediately.
Depending on the symptoms, your doctor will provide the necessary treatment. Since doxazosin is highly bound to plasma proteins, dialysis is not likely to be effective in treating overdose.
If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next dose. In this case, skip the missed dose and take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet.
If you stop taking DOZOX suddenly, your condition may worsen. Therefore, do not stop taking this medicine without consulting your doctor. The dose should be gradually reduced by your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Very rare side effects(may affect less than 1 in 1,000 people)
Unknown frequency(cannot be estimated from the available data)
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Pharmacovigilance Department, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw, tel: +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a temperature below 30°C.
Do not use this medicine after the expiry date which is stated on the packaging after "EXP".
The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
DOZOX is available as white, oval tablets with a score line and the marking "D" "4" on one side. The tablet can be divided into equal doses.
The tablets are packaged in PVC/PVDC/Aluminum blisters.
Package sizes: 20, 30, or 90 tablets in a cardboard box.
Not all package sizes may be marketed.
+pharma arzneimittel gmbh
Hafnerstraße 211
8054 Graz
Austria
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13
4042 Debrecen
Hungary
For more information on this medicine, contact the representative of the marketing authorization holder:
+pharma Polska sp. z o.o.
ul. Podgórska 34
31-536 Kraków, Poland
tel: +48 12 262 32 36
e-mail: krakow@pluspharma.eu
Date of last revision of the leaflet:May 2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.